Many individuals living with cancer are protected from COVID-19. However, some people living with cancer have increased risk of hospitalisation and mortality from COVID-19.
Vaccination and boosters are recommended for individuals who are on anti-cancer treatments. However, some individuals may have a less effective immune response and lower antibody levels. Research is required to understand the protection provided by antibodies generated following COVID-19 infection and vaccination.
It is important to safeguard, monitor and protect people with cancer. In direct response, the National COVID cancer survey was launched in September 2021 across England. The survey will provide crucial insights to aid wider efforts to safeguard, protect and monitor vulnerable groups and those living with and beyond cancer.